SPARCL1 and cancer: Studies showed that the SPARCL1 gene may be associated with the Wnt/β-catenin pathway and has a role in cancer as well as other diseases, so we tested whether the SPARCL1 gene can regulate the Wnt/β-catenin pathway affecting preadipocyte differentiation [17,18].